Bainan Biotech is a spinout company which is founded on years of research exploring the connection between gut hormones and bone turnover, carried out at the University of Copenhagen. We aim to utilise the natural responses to eating in order to promote the formation of stronger and healthier bone tissue and develop effective treatments for osteoporosis. Specifically, we are adapting our products to be effective in premenopausal women, a patient group which currently is vastly under-served in this area.